Research programme: serotonin 2A receptor agonists - AlconAlternative Names: AL-34659; Serotonin 2A receptor agonists research programme - Alcon
Latest Information Update: 12 Apr 2010
At a glance
- Originator Alcon
- Mechanism of Action Serotonin 2 receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Glaucoma
Most Recent Events
- 06 Apr 2006 This programme is still in active development
- 04 Sep 2005 Preclinical trials in Glaucoma in USA (Topical)